English
Русский
Eco-vector
Perm Medical Journal
ISSN 0136-1449 (Print) ISSN 2687-1408 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Team
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Articles in press
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • All Journals

User
Forgot password? Register
Notifications
  • View
  • Subscribe
Search
Browse
  • By Issue
  • By Author
  • By Title
  • By Sections
  • Other Journals
  • Categories
BMJ Open News
The Lancet News
  • [07.12.2025] [Comment] A step forward in the treatment of relapsed or refractory...
  • [07.12.2025] [Articles] Epcoritamab, lenalidomide, and rituximab versus lenalidomide and...
  • [06.12.2025] [Comment] A new standard for relapsed or refractory follicular lymphoma
  • [06.12.2025] [Articles] Tafasitamab, lenalidomide, and rituximab in relapsed or refractory...
  • [05.12.2025] [World Report] Aid cuts hampering Nepal's tuberculosis care
PubMed News Global
  • [07.12.2025] Adipose tissue metabolomics identifies disease stage and tumour invasiveness...
  • [07.12.2025] Co-learning in crisis: A comparative analysis of digital preparedness during...
  • [07.12.2025] Spatio-environmental surveillance of organochlorine pesticides in the Meghna...
  • [07.12.2025] The Israeli eye care system through a public and global health lens
  • [07.12.2025] PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients...
×

User
Forgot password? Register
Notifications
  • View
  • Subscribe
Search
Browse
  • By Issue
  • By Author
  • By Title
  • By Sections
  • Other Journals
  • Categories
BMJ Open News
The Lancet News
  • [07.12.2025] [Comment] A step forward in the treatment of relapsed or refractory...
  • [07.12.2025] [Articles] Epcoritamab, lenalidomide, and rituximab versus lenalidomide and...
  • [06.12.2025] [Comment] A new standard for relapsed or refractory follicular lymphoma
  • [06.12.2025] [Articles] Tafasitamab, lenalidomide, and rituximab in relapsed or refractory...
  • [05.12.2025] [World Report] Aid cuts hampering Nepal's tuberculosis care
PubMed News Global
  • [07.12.2025] Adipose tissue metabolomics identifies disease stage and tumour invasiveness...
  • [07.12.2025] Co-learning in crisis: A comparative analysis of digital preparedness during...
  • [07.12.2025] Spatio-environmental surveillance of organochlorine pesticides in the Meghna...
  • [07.12.2025] The Israeli eye care system through a public and global health lens
  • [07.12.2025] PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients...
Home > Search > Author Details

Author Details

Manyakina, O. M.

Issue Section Title File
Vol 35, No 6 (2018) Clinical studies Peculiar features of inflammatory process in gastric mucosa with different character of its bacterioviral infection in adolescents with chronic gastritis PDF
(Rus)
Vol 36, No 1 (2019) Clinical studies Coinfection of gastric mucosa with Helicobacter Pylori and Epstein-Barr virus as a factor of ineffectiveness of antihelicobacter chronic gastritis therapy in adolescents PDF
(Rus)
Vol 37, No 6 (2020) Original studies Influence of genetic characteristics of Helicobacter pylori on pathomorphology of gastric mucosa in young persons with chronic gastritis PDF
(Rus)
Vol 38, No 1 (2021) Review of literature Role of genetic structure of Helicobacter Pylori in formation of chronic inflammatory process in gastric mucosa PDF
(Rus)
Vol 38, No 6 (2021) Original studies Clinical variants of chronic gastritis in childhood PDF
(Rus)
Vol 39, No 1 (2022) Original studies Cellular composition of gastric glands in chronic gastritis among children PDF
(Rus)


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 75489 от 05.04.2019 г
.

 

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP